Exact FDA event identifier

Event 88453

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket: July 30, 2021
Product types: Device
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Leica Microsystems, Inc.

Dossier provenance

Source snapshots represented here

openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 1

BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375

Z-2481-2021

Recall number: Z-2481-2021
Initiated: July 30, 2021
Classification: Class II
Status: Terminated
Recalling firm: Leica Microsystems, Inc.
Quantity: 237 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Product may not perform as specified in IFU.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Unknown

An exact joined enrichment record exists, but none supplies supported root-cause wording. This is not an FDA finding of an unknown cause.

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Product may not perform as specified in IFU.

Code information

Product Code PA0375, Lot 69909

Distribution pattern

US Nationwide distribution.